Something I noticed reading old threads that I have not seen said out loud. The advice on NHS in this community changed substantially around the start of last year, and…
u/marit_coelho
Contributes reviews on supplier material. Based in Brno.
member · joined 13 Apr 2025
Overview — page 4 of 5
comment on [Question] Ireland — has anyone got a straight answer on private plan in c/glp1canada · 172 points · 1 year ago
the 3 province variation is real
comment on my fasting insulin moved and I cannot work out whether pricing is why in c/glp1uk · -11 points · 1 year ago
Not convinced. The evidence does not support that reading.
comment on what changed for me between week 60 and week 8 in c/orforglipron · 32 points · 1 year ago
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
comment on food noise: what the trials say vs what this community says in c/semaglutide · 179 points · 1 year ago
week 67 and i am still not at maintenance, do not rush the ladder
comment on someone explain pricing to me like I have not read a paper in years in c/glp1uk · 571 points · 1 year ago
Titration speed is a side-effect dial far more than an efficacy dial.
comment on small win: constipation stopped being a problem at week 75 in c/sideeffects · 15 points · 1 year ago
The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.
comment on genuine question about ATTAIN that I am slightly embarrassed to ask in c/orforglipron · 12 points · 1 year ago
Australia here. Waited 11 months on a list, gave up, went private, and the total cost was roughly what I expected.
comment on anyone else notice Wegovy kicking in around week 39 in c/semaglutide · 101 points · 1 year ago
the 2.4mg dose is not the target, it is just what the pen goes up to
comment on small win: Ozempic stopped being a problem at week 70 in c/semaglutide · 292 points · 1 year ago
Canada here. Waited 16 months on an NHS list, gave up, went private, and the cost was half what I expected but the admin was worse.
comment on [Meta] the Canada rule is doing its job and people should stop complaining in c/glp1canada · 14 points · 1 year ago
provincial formularies differ sharply
comment on the tier 3 question that gets asked weekly, answered properly in c/glp1uk · 93 points · 2 years ago
This is correct. Private and NHS pathways are different.
comment on [Discussion] can we stop arguing about MHRA until somebody posts a number in c/glp1uk · 561 points · 2 years ago
Disagree. What you are describing is consistent with UK, not with what you concluded.
comment on [Discussion] the 2.4mg advice in here is 17 years out of date in c/semaglutide · 1 points · 2 years ago
titration speed is titration plus side effects, period
comment on ATTAIN: the version I wish someone had shown me in week 1 in c/orforglipron · 3 points · 2 years ago
oral non-peptide agonist is ACHIEVE, no food restrictions
Adding to this: oral GLP-1 is doing more work than the comment implies.
comment on [Lab] 21th independent test on BCH, and the trend is the interesting part in c/glp1uk · -6 points · 2 years ago
the Scottish pathway is different from the English one
comment on [Results] 17 weeks, 35kg, and special authorization was the hard part in c/glp1canada · 154 points · 2 years ago
private plans vary by employer
comment on three years of reimbursement threads, summarised so you do not have to read them in c/glp1eu · 8 points · 2 years ago
EMA and national agency claims need citation
comment on 4 months in and Canada is still the thing I get wrong in c/glp1canada · 16 points · 2 years ago
the the Netherlands answer is not the the Netherlands answer
comment on 20 months in and non-peptide is still the thing I get wrong in c/orforglipron · 22 points · 2 years ago
the early fullness profile is speculative at this stage